title: Consequences of the REDOXS and METAPLUS Trials: The End of an Era of Glutamine and Antioxidant Supplementation for Critically Ill Patients?
authors.affiliation: Department of Intensive Care, Gelderse Vallei Hospital, Ede, the Netherlands.
authors.forename: Arthur R H
authors.initials: AR
authors.lastname: van Zanten
authors.affiliation: Nutricia Advanced Medical Nutrition, Nutricia Research, Utrecht, the Netherlands.
authors.forename: Zandrie
authors.initials: Z
authors.lastname: Hofman
authors.affiliation: Clinical Evaluation Research Unit, Kingston General Hospital, Kingston, Ontario, Canada dkh2@queensu.ca.
authors.forename: Daren K
authors.initials: DK
authors.lastname: Heyland
mesh_terms: D000975:Antioxidants / Q000009:adverse effects* / Q000627:therapeutic use; D003422:Critical Care; D016638:Critical Illness / Q000401:mortality / Q000628:therapy*; D019587:Dietary Supplements / Q000009:adverse effects*; D005973:Glutamine / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D018529:Nutritional Support; D017410:Practice Guidelines as Topic
chemical_list: D000975:Antioxidants; D005973:Glutamine
keywords: amino acids; critical care; enteral nutrition; immunonutrition; nutrition; parenteral nutrition; research and diseases